Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- PMID: 37478286
- DOI: 10.1111/jdv.19377
Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
References
REFERENCES
-
- Alessandrini A, Starace M, Bruni F, Brandi N, Baraldi C, Misciali C, et al. Alopecia areata incognita and diffuse alopecia areata: clinical, trichoscopic, histopathological, and therapeutic features of a 5-year study. Dermatol Pract Concept. 2019;9(4):272-277.
-
- European Medicines Agents (EMA) [Internet]. [updated 2023 Apr 12; cited 2023 Feb 18]. Avaible from: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/rinvoq-4
-
- Liu C, Ding SS, Zhang K, Liu LN, Guo LH, Sun LP, et al. Correlation between ultrasound consolidated score and simple endoscopic score for determining the activity of Crohn's disease. Br J Radiol. 2020;93(1109):20190614.
-
- Phan K, Sebaratnam DF. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(5):850-856.
-
- Sobolewska-Włodarczyk A, Włodarczyk M, Fichna J, Wiśniewska-Jarosińska M. Alopecia areata in patients with inflammatory bowel disease: an overview. Folia Med Cracov. 2016;56(1):5-12.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
